News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

AirWare Labs Announces Its Patented AIR® Products for Defense Against Flu & Allergy



1/29/2013 9:08:35 AM

SCOTTSDALE, AZ--(Marketwire - January 29, 2013) -

AirWare Labs Corp. (OTCQB: AIRW) today announced it will expand its sales and promotional marketing efforts of the AIR® Allergy product in addition to the Sleep/Snore product as part of its continued commitment to a national rollout at Walgreens 7500 stores.

AIR® products are developed with essential oils and filtration media for defense against airborne allergens, viruses and bacteria. AIR® Allergy defense comes from an integrated filter to remove microscopic particles that carry viruses and bacteria. AIR's® patented design utilizes an intranasal microstructure that is fabricated to deliver up to 40% more airflow. AIR® products are manufactured with an FDA approved medical grade silicon with some product lines infused with therapeutic essential oils. The AIR® Allergy product is well positioned in defense of the Flu with Eucalyptus Oil that is scientifically shown to be a natural antimicrobial that possesses disinfecting properties.

AirWare Labs has launched new marketing efforts to expand awareness for defense of the Flu. Internet search campaigns are underway to promote AIR's® Allergy defense capabilities in context to the increased need for protection and resistance to Flu symptoms. By utilizing search-marketing terms that answers the millions of online searches seeking protection and relief this Flu season, these efforts should lead to conversions for both online and in-store sales.

Demand for products that defend against the Flu and Allergies are at record levels. Internet searches meteoric spikes coincides with the current CDC trend reporting influenza activity remaining very high and widespread nationally. Current reports of patient visits have exceeded 4.6% this year; more than double the national baseline average of 2.2%. Furthermore, major media outlets are actively reporting that "presenteeism" (the act of attending work while sick) is further exacerbating the spread of germs that cause the Flu.

"Unlike the masks you sometimes see in other countries to protect from -- and against -- germs from co-workers and the general public, we have a discrete and better solution. AIR® Allergy offers increased intranasal protection where we believe the flu is often contracted. Once customers experience the healthy by-product of increased oxygen flow, decreased air pollutants and the wellness benefits of essential therapeutic oils in AIR® products, we are confident our products will quickly become the preferred choice for drug-free relief for common ailments and sleepless nights," said Jeffrey Rassás, President & CEO of AirWare Labs.

"The unique features and benefits of the AIR® product line allowed us to engage the best retailers in the OTC business for healthcare products. As retail interest in AIR's® delivery system for Allergies, Decongestant, Headache, Nausea, Sleep/Snore and other ailments protection continues to grow, Quest is pleased to be a strategic partner and distribution arm for AirWare Labs and growth of its AIR® product offering," said Don Ryan, CEO of Quest Products, Inc.

About AirWare Labs Corporation

AirWare Labs (www.airwarelabs.com) provides patented & innovative technology solutions to consumer products promoting better health and enhanced wellbeing. AirWare Labs' products are marketed under the family name of AIR® by AirWare Labs. AIR® Products start with an FDA approved medical grade silicone molded as an intranasal Air Breathe dilator; this is the AIR® delivery system. This microstructure enhances normal nasal airflow with every breath clinically proven to deliver up to 40% more oxygen. Certain AIR® products are infused with essential oils with unique healing properties including antibacterial and therapeutic defense against airborne allergens, viruses and bacteria. AIR® Allergy and Travel products have additional defense in the form of an integrated filter media from 3M to remove microscopic particles that carry viruses, Allergens and bacteria. Other AIR® products specialize in helping with congestion, insomnia, headaches, nausea, snoring and performance enhancements.

About Quest

Quest Products Inc. (www.questproductsinc.com) provides turnkey solutions to CPG companies looking to develop their product's distribution and sales to all classes of trade. Quest works with varying sizes of CPG companies, from inventors and entrepreneurs beginning the start-up brands, to large industry leading CPG manufacturers looking to expand their reach. Quest's unique core competencies allow them to create turnkey solutions and drive new and incremental opportunities in sales for their client partners. Quest Sales Team works with food, drug and mass retailers across the USA and Canada, including Wal-Mart, Target, CVS and Walgreens. Quest was listed as one of the fastest growing companies four years in a row by INC. Magazine.

Cautionary Note Regarding Forward-Looking Statements

This press release contains forward-looking statements that involve risks and uncertainties, including the Company's beliefs about its business prospects and future results of operations. These results may not indicative of the result achieved in the entire tailings pile do to the non-homogenous nature of the pile itself. Some factors that could cause actual results to differ materially include economic and operational risks, changes in anticipated earnings, continuation of current contracts, and other factors detailed in the Company's filings with the Securities and Exchange Commission, including its most recent Forms 10-KSB and 10-QSB. The Company forecasts provided above are dynamic and therefore refer only to this release date. The Company does not undertake to update any forecasts that it may make available to the investing public. Please visit airwarelabscorp.com


Contact:

Media
Kevin Myers
602.705.3454
Email Contact

Investor Relations
Jeffrey Rassas
480.463.4246

Digg this    Bookmark with del.icio.us    Add to Newsvine

Technorati:


Read at BioSpace.com


comments powered by Disqus
 
 
Influenza

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES